Skip to main content
Log in

Amyloid peptides with antimicrobial and/or microbial agglutination activity

  • Mini-Review
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Microbe (including bacteria, fungi, and virus) infection in brains is associated with amyloid fibril deposit and neurodegeneration. Increasing findings suggest that amyloid proteins, like Abeta (Aβ), are important innate immune effectors in preventing infections. In some previous studies, amyloid peptides have been linked to antimicrobial peptides due to their common mechanisms in membrane-disruption ability, while the other mechanisms of bactericidal protein aggregation and protein function knockdown are less discussed. Besides, another important function of amyloid peptides in pathogen agglutination is rarely illustrated. In this review, we summarized and divided the different roles and mechanisms of amyloid peptides against microbes in antimicrobial activity and microbe agglutination activity. Besides, the range of amyloids’ antimicrobial spectrum, the effectiveness of amyloid peptide states (monomers, oligomers, and fibrils), and cytotoxicity are discussed. The good properties of amyloid peptides against microbes might provide implications for the development of novel antimicrobial drug.

Key points

Antimicrobial and/or microbial agglutination is a characteristic of amyloid peptides.

Various mechanisms of amyloid peptides against microbes are discovered recently.

Amyloid peptides might be developed into novel antimicrobial drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article.

References 

  • Abdelrahman S, Alghrably M, Lachowicz JI, Emwas A, Hauser CAE, Jaremko M (2020) “What doesn’t kill you makes you stronger”: future applications of amyloid aggregates in biomedicine. Molecules 25:5245

    Article  CAS  PubMed Central  Google Scholar 

  • Adler-Abramovich L, Gazit E (2014) The physical properties of supramolecular peptide assemblies: from building block association to technological applications. CHEM SOC REV 43:6881–6893

    Article  CAS  PubMed  Google Scholar 

  • Auvynet C, El AC, Lacombe C, Bruston F, Bourdais J, Nicolas P, Rosenstein Y (2008) Structural requirements for antimicrobial versus chemoattractant activities for dermaseptin S9. FEBS J 275:4134–4151

    Article  CAS  PubMed  Google Scholar 

  • Babych M, Bertheau-Mailhot G, Zottig X, Dion J, Gauthier L, Archambault D, Bourgault S (2018) Engineering and evaluation of amyloid assemblies as a nanovaccine against the Chikungunya virus. Nanoscale 10:19547–19556

    Article  CAS  PubMed  Google Scholar 

  • Bednarska NG, van Eldere J, Gallardo R, Ganesan A, Ramakers M, Vogel I, Baatsen P, Staes A, Goethals M, Hammarstrom P, Nilsson KP, Gevaert K, Schymkowitz J, Rousseau F (2016) Protein aggregation as an antibiotic design strategy. MOL MICROBIOL 99:849–865

    Article  CAS  PubMed  Google Scholar 

  • Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva M, Sekijima Y, Sipe JD, Westermark P (2020) Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 27:217–222

    Article  CAS  PubMed  Google Scholar 

  • Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ (2004) Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A 101:8455–8460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bouaziz Z, Soussan L, Janot JM, Lepoitevin M, Bechelany M, Djebbi MA, Amara A, Balme S (2017) Structure and antibacterial activity relationships of native and amyloid fibril lysozyme loaded on layered double hydroxide. Colloids Surf B Biointerfaces 157:10–17

    Article  CAS  PubMed  Google Scholar 

  • Bourgade K, Dupuis G, Frost EH, Fulop T (2016) Anti-viral properties of amyloid-beta peptides. J ALZHEIMERS DIS 54:859–878

    Article  CAS  PubMed  Google Scholar 

  • Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507–511

    Article  CAS  PubMed  Google Scholar 

  • Butterfield SM, Lashuel HA (2010) Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. Angew Chem Int Ed Engl 49:5628–5654

    Article  CAS  PubMed  Google Scholar 

  • Caillon L, Killian JA, Lequin O, Khemtemourian L (2013) Biophysical investigation of the membrane-disrupting mechanism of the antimicrobial and amyloid-like peptide dermaseptin S9. PLoS ONE 8:e75528

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen D, Cao Y, Yu L, Tao Y, Zhou Y, Zhi Q, Lin H (2019) Characteristics and influencing factors of amyloid fibers in S. mutans biofilm. AMB EXPRESS 9:31

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen D, Li J, Pan T, Wu R, Tao Y, Lin H (2021) The broad-spectrum antibiofilm activity of amyloid-forming hexapeptides. MICROB BIOTECHNOL 14:656–667

    Article  CAS  PubMed  Google Scholar 

  • Chu H, Pazgier M, Jung G, Nuccio SP, Castillo PA, de Jong MF, Winter MG, Winter SE, Wehkamp J, Shen B, Salzman NH, Underwood MA, Tsolis RM, Young GM, Lu W, Lehrer RI, Baumler AJ, Bevins CL (2012) Human alpha-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 337:477–481

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Das S, Jacob RS, Patel K, Singh N, Maji SK (2018) Amyloid fibrils: versatile biomaterials for cell adhesion and tissue engineering applications. Biomacromol 19:1826–1839

    Article  CAS  Google Scholar 

  • De Baets G, Schymkowitz J, Rousseau F (2014) Predicting aggregation-prone sequences in proteins. ESSAYS BIOCHEM 56:41–52

    Article  PubMed  Google Scholar 

  • Egorov VV, Matusevich OV, Shaldzhyan AA, Skvortsov AN, Zabrodskaya YA, Garmay YP, Landa SB, Lebedev DV, Zarubayev VV, Sirotkin AK, Vasin AV, Kiselev OI (2013) Structural features of the peptide homologous to 6–25 fragment of influenza A PB1 protein. Int J Pept 2013:370832

    Article  PubMed  PubMed Central  Google Scholar 

  • Eimer WA, Vijaya KD, Navalpur SN, Rodriguez AS, Mitchell T, Washicosky KJ, Gyorgy B, Breakefield XO, Tanzi RE, Moir RD (2018) Alzheimer’s disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99:56–63

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ezzat K, Pernemalm M, Palsson S, Roberts TC, Jarver P, Dondalska A, Bestas B, Sobkowiak MJ, Levanen B, Skold M, Thompson EA, Saher O, Kari OK, Lajunen T, Sverremark EE, Nilsson C, Ishchenko Y, Malm T, Wood M, Power UF, Masich S, Linden A, Sandberg JK, Lehtio J, Spetz AL, El AS (2019) The viral protein corona directs viral pathogenesis and amyloid aggregation. NAT COMMUN 10:2331

    Article  PubMed  PubMed Central  Google Scholar 

  • Gallardo R, Ramakers M, De Smet F, Claes F, Khodaparast L, Khodaparast L, Couceiro JR, Langenberg T, Siemons M, Nystrom S, Young LJ, Laine RF, Young L, Radaelli E, Benilova I, Kumar M, Staes A, Desager M, Beerens M, Vandervoort P, Luttun A, Gevaert K, Bormans G, Dewerchin M, Van Eldere J, Carmeliet P, Vande VG, Verfaillie C, Kaminski CF, De Strooper B, Hammarstrom P, Nilsson KP, Serpell L, Schymkowitz J, Rousseau F (2016) De novo design of a biologically active amyloid. SCIENCE 354(6313):aah4949

    Article  PubMed  Google Scholar 

  • Gosztyla ML, Brothers HM, Robinson SR (2018) Alzheimer’s amyloid-beta is an antimicrobial peptide: a review of the evidence. J ALZHEIMERS DIS 62:1495–1506

    Article  CAS  PubMed  Google Scholar 

  • Harris F, Dennison SR, Phoenix DA (2012) Aberrant action of amyloidogenic host defense peptides: a new paradigm to investigate neurodegenerative disorders? FASEB J 26:1776–1781

    Article  CAS  PubMed  Google Scholar 

  • Hirakura Y, Carreras I, Sipe JD, Kagan BL (2002) Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense. Amyloid 9:13–23

    Article  CAS  PubMed  Google Scholar 

  • Holch A, Bauer R, Olari LR, Rodriguez AA, Standker L, Preising N, Karacan M, Wiese S, Walther P, Ruiz-Blanco YB, Sanchez-Garcia E, Schumann C, Munch J, Spellerberg B (2020) Respiratory ss-2-Microglobulin exerts pH dependent antimicrobial activity. VIRULENCE 11:1402–1414

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Housmans JAJ, Wu G, Schymkowitz J, Rousseau F (2021) A guide to studying protein aggregation. The FEBS Journal. https://doi.org/10.1111/febs.16312

  • Idrees D, Kumar V (2021) SARS-CoV-2 spike protein interactions with amyloidogenic proteins: potential clues to neurodegeneration. Biochem Biophys Res Commun 554:94–98

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jackson JW, Hancock TJ, Dogra P, Patel R, Arav-Boger R, Williams AD, Kennel SJ, Wall JS, Sparer TE (2019) Anticytomegalovirus peptides point to new insights for CMV entry mechanisms and the limitations of in vitro screenings. msphere 4(1):e00586–18

  • Jana AK, Greenwood AB, Hansmann UH (2021) Presence of a SARS-COV-2 protein enhances Amyloid Formation of Serum Amyloid A. J Phys Chem B 125(32):9155–9167

  • Jang H, Arce FT, Mustata M, Ramachandran S, Capone R, Nussinov R, Lal R (2011) Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link. BIOPHYS J 100:1775–1783

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Juhl DW, Glattard E, Lointier M, Bampilis P, Bechinger B (2020) The reversible non-covalent aggregation into fibers of PGLa and Magainin 2 preserves their antimicrobial activity and synergism. Front Cell Infect Microbiol 10:526459

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kagan BL, Jang H, Capone R, Teran AF, Ramachandran S, Lal R, Nussinov R (2012) Antimicrobial properties of amyloid peptides. Mol Pharm 9:708–717

    Article  CAS  PubMed  Google Scholar 

  • Khodaparast L, Khodaparast L, Gallardo R, Louros NN, Michiels E, Ramakrishnan R, Ramakers M, Claes F, Young L, Shahrooei M, Wilkinson H, Desager M, Mengistu TW, Nilsson K, Hammarstrom P, Aertsen A, Carpentier S, Van Eldere J, Rousseau F, Schymkowitz J (2018) Aggregating sequences that occur in many proteins constitute weak spots of bacterial proteostasis. NAT COMMUN 9:866

    Article  PubMed  PubMed Central  Google Scholar 

  • Kokotidou C, Jonnalagadda S, Orr AA, Vrentzos G, Kretsovali A, Tamamis P, Mitraki AA (2019) Designer amyloid cell-penetrating peptides for potential use as gene transfer vehicles. Biomolecules 10(1):7

    Article  PubMed Central  Google Scholar 

  • Kravchenko SV, Domnin PA, Grishin SY, Panfilov AV, Azev VN, Mustaeva LG, Gorbunova EY, Kobyakova MI, Surin AK, Glyakina AV, Fadeev RS, Ermolaeva SA, Galzitskaya OV (2022) Multiple antimicrobial effects of hybrid peptides synthesized based on the sequence of ribosomal S1 protein from Staphylococcus aureus. INT J MOL SCI 23(1):524

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, Lefkowitz A, McColl G, Goldstein LE, Tanzi RE, Moir RD (2016) Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. SCI TRANSL MED 8:340r–372r

    Article  Google Scholar 

  • Kurpe S, Grishin S, Surin A, Selivanova O, Fadeev R, Dzhus U, Gorbunova E, Mustaeva L, Azev V, Galzitskaya O (2020) Antimicrobial and amyloidogenic activity of peptides synthesized on the basis of the ribosomal S1 Protein from Thermus thermophilus. INT J MOL SCI 21:6382

    Article  CAS  PubMed Central  Google Scholar 

  • Kurpe SR, Grishin SY, Surin AK, Panfilov AV, Slizen MV, Chowdhury SD, Galzitskaya OV (2020) Antimicrobial and amyloidogenic activity of peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2? INT J MOL SCI 21:9552

    Article  CAS  PubMed Central  Google Scholar 

  • Last NB, Miranker AD (2013) Common mechanism unites membrane poration by amyloid and antimicrobial peptides. Proc Natl Acad Sci U S A 110:6382–6387

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mahalka AK, Kinnunen PK (2009) Binding of amphipathic alpha-helical antimicrobial peptides to lipid membranes: lessons from temporins B and L. Biochim Biophys Acta 1788:1600–1609

    Article  CAS  PubMed  Google Scholar 

  • Makin S (2018) The Amyloid Hypothesis on Trial NATURE 559:S4–S7

    CAS  PubMed  Google Scholar 

  • Michiels E, Roose K, Gallardo R, Khodaparast L, Khodaparast L, van der Kant R, Siemons M, Houben B, Ramakers M, Wilkinson H, Guerreiro P, Louros N, Kaptein S, Ibanez LI, Smet A, Baatsen P, Liu S, Vorberg I, Bormans G, Neyts J, Saelens X, Rousseau F, Schymkowitz J (2020) Reverse engineering synthetic antiviral amyloids. NAT COMMUN 11:2832

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moir RD, Lathe R, Tanzi RE (2018) The antimicrobial protection hypothesis of Alzheimer’s disease. ALZHEIMERS DEMENT 14:1602–1614

    Article  PubMed  Google Scholar 

  • Mukherjee SK, Knop JM, Winter R (2022) Modulation of the conformational space of SARS-CoV-2 RNA quadruplex RG-1 by cellular components and the amyloidogenic peptides alpha-synuclein and hIAPP. Chemistry 28:e202104182

    CAS  PubMed  PubMed Central  Google Scholar 

  • Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Gimenez-Gallego G, Sanchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F (2007) Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131:1059–1071

    Article  PubMed  Google Scholar 

  • Nilsson MR, Dobson CM (2003) In vitro characterization of lactoferrin aggregation and amyloid formation. BIOCHEMISTRY-US 42:375–382

    Article  CAS  Google Scholar 

  • Otzen D, Riek R (2019) Functional amyloids. Cold Spring Harb Perspect Biol 11(2):a033860

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Palika A, Armanious A, Rahimi A, Medaglia C, Gasbarri M, Handschin S, Rossi A, Pohl MO, Busnadiego I, Gubeli C, Anjanappa RB, Bolisetty S, Peydayesh M, Stertz S, Hale BG, Tapparel C, Stellacci F, Mezzenga R (2021) An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles. NAT NANOTECHNOL 16:918–925

    Article  CAS  PubMed  Google Scholar 

  • Pasupuleti M, Roupe M, Rydengard V, Surewicz K, Surewicz WK, Chalupka A, Malmsten M, Sorensen OE, Schmidtchen A (2009) Antimicrobial activity of human prion protein is mediated by its N-terminal region. PLoS ONE 4:e7358

    Article  PubMed  PubMed Central  Google Scholar 

  • Pulido D, Moussaoui M, Andreu D, Nogues MV, Torrent M, Boix E (2012) Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure. Antimicrob Agents Chemother 56:2378–2385

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ridge RJ, Paus EJ, Novitsky TJ, Ketchum PA (2000) Reversible binding of heparin to the loop peptide of endotoxin neutralizing protein. J Endotoxin Res 6:17–23

    Article  CAS  PubMed  Google Scholar 

  • Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. NAT MED 10(Suppl):S10–S17

    Article  PubMed  Google Scholar 

  • Salinas N, Colletier JP, Moshe A, Landau M (2018) Extreme amyloid polymorphism in Staphylococcus aureus virulent PSMalpha peptides. NAT COMMUN 9:3512

    Article  PubMed  PubMed Central  Google Scholar 

  • Schnaider L, Brahmachari S, Schmidt NW, Mensa B, Shaham-Niv S, Bychenko D, Adler-Abramovich L, Shimon L, Kolusheva S, DeGrado WF, Gazit E (2017) Self-assembling dipeptide antibacterial nanostructures with membrane disrupting activity. NAT COMMUN 8:1365

    Article  PubMed  PubMed Central  Google Scholar 

  • Semerdzhiev SA, Fakhree M, Segers-Nolten I, Blum C, Claessens M (2022) Interactions between SARS-CoV-2 N-protein and alpha-synuclein accelerate amyloid formation. ACS CHEM NEUROSCI 13:143–150

    Article  CAS  PubMed  Google Scholar 

  • Sood R, Domanov Y, Pietiainen M, Kontinen VP, Kinnunen PK (2008) Binding of LL-37 to model biomembranes: insight into target vs host cell recognition. Biochim Biophys Acta 1778:983–996

    Article  CAS  PubMed  Google Scholar 

  • Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD (2010) The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS ONE 5:e9505

    Article  PubMed  PubMed Central  Google Scholar 

  • Spitzer P, Condic M, Herrmann M, Oberstein TJ, Scharin-Mehlmann M, Gilbert DF, Friedrich O, Gromer T, Kornhuber J, Lang R, Maler JM (2016) Amyloidogenic amyloid-beta-peptide variants induce microbial agglutination and exert antimicrobial activity. Sci Rep 6:32228

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tavassoly O, Safavi F, Tavassoly I (2020) Seeding brain protein aggregation by SARS-CoV-2 as a possible long-term complication of COVID-19 infection. ACS CHEM NEUROSCI 11:3704–3706

    Article  CAS  PubMed  Google Scholar 

  • Tavassoly O, Safavi F, Tavassoly I (2020) Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection. MOL PHARMACOL 98:612–619

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Torrent M, Pulido D, Nogues MV, Boix E (2012) Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation. PLOS PATHOG 8:e1003005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsai PW, Yang CY, Chang HT, Lan CY (2011) Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE 6:e17755

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tu W, Xue K, Lou S, Zhu C, Yu Z (2021) Self-assembly of virulent amyloid-derived peptides into nanoantibacterials. Nanoscale 13:9864–9872

    Article  CAS  PubMed  Google Scholar 

  • Valincius G, Heinrich F, Budvytyte R, Vanderah DJ, McGillivray DJ, Sokolov Y, Hall JE, Losche M (2008) Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity. BIOPHYS J 95:4845–4861

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vaquer-Alicea J, Diamond MI (2019) Propagation of protein aggregation in neurodegenerative diseases. ANNU REV BIOCHEM 88:785–810

    Article  CAS  PubMed  Google Scholar 

  • Voth S, Gwin M, Francis CM, Balczon R, Frank DW, Pittet JF, Wagener BM, Moser SA, Alexeyev M, Housley N, Audia JP, Piechocki S, Madera K, Simmons A, Crawford M, Stevens T (2020) Virulent Pseudomonas aeruginosa infection converts antimicrobial amyloids into cytotoxic prions. FASEB J 34:9156–9179

    Article  CAS  PubMed  Google Scholar 

  • Walsh P, Vanderlee G, Yau J, Campeau J, Sim VL, Yip CM, Sharpe S (2014) The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by prion protein(106–126) is dependent on bilayer composition. J BIOL CHEM 289:10419–10430

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang L, Liu Q, Chen JC, Cui YX, Zhou B, Chen YX, Zhao YF, Li YM (2012) Antimicrobial activity of human islet amyloid polypeptides: an insight into amyloid peptides’ connection with antimicrobial peptides. BIOL CHEM 393:641–646

    Article  CAS  PubMed  Google Scholar 

  • Wang R, Yang X, Cui L, Yin H, Xu S (2019) Gels of Amyloid Fibers Biomolecules 9:210

    CAS  Google Scholar 

  • Wei G, Su Z, Reynolds NP, Arosio P, Hamley IW, Gazit E, Mezzenga R (2017) Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology. CHEM SOC REV 46:4661–4708

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wei Z, Wu S, Xia J, Shao P, Sun P, Xiang N (2021) Enhanced antibacterial activity of hen egg-white lysozyme against Staphylococcus aureus and Escherichia coli due to Protein Fibrillation. Biomacromol 22:890–897

    Article  CAS  Google Scholar 

  • White MR, Kandel R, Tripathi S, Condon D, Qi L, Taubenberger J, Hartshorn KL (2014) Alzheimer’s associated beta-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS ONE 9:e101364

    Article  PubMed  PubMed Central  Google Scholar 

  • Wozniak MA, Mee AP, Itzhaki RF (2009) Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. J PATHOL 217:131–138

    Article  CAS  PubMed  Google Scholar 

  • Xia X (2021) Domains and functions of spike protein in SARS-Cov-2 in the context of vaccine design. Viruses 13:109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zabrodskaya YA, Lebedev DV, Egorova MA, Shaldzhyan AA, Shvetsov AV, Kuklin AI, Vinogradova DS, Klopov NV, Matusevich OV, Cheremnykh TA, Dattani R, Egorov VV (2018) The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity. BIOPHYS CHEM 234:16–23

    Article  CAS  PubMed  Google Scholar 

  • Zhang M, Zhao J, Zheng J (2014) Molecular understanding of a potential functional link between antimicrobial and amyloid peptides. Soft Matter 10:7425–7451

    Article  CAS  PubMed  Google Scholar 

  • Zhao C, Qin G, Niu J, Wang Z, Wang C, Ren J, Qu X (2021) Targeting RNA G-Quadruplex in SARS-CoV-2: a promising therapeutic target for COVID-19? Angew Chem Int Ed Engl 60:432–438

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huancai Lin.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 173 KB) (download PDF )

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, D., Liu, X., Chen, Y. et al. Amyloid peptides with antimicrobial and/or microbial agglutination activity. Appl Microbiol Biotechnol 106, 7711–7720 (2022). https://doi.org/10.1007/s00253-022-12246-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1007/s00253-022-12246-w

Keywords

Profiles

  1. Huancai Lin